Drug intelligence / Profile preview

Citrus + Cydonia comp.

Development stage
Unknown
Lead developer
Weleda
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Subcutaneous, Intranasal
01

Overview

Citrus + Cydonia comp. (marketed under the brand name **Gencydo**) is an anthroposophic medicinal product developed by **Weleda AG** for the treatment of seasonal allergic rhinitis (hay fever). It is a botanical preparation consisting of extracts from lemon juice (*Citrus limon*) and an aqueous extract of quince fruit (*Cydonia oblonga*). The drug acts as an immunomodulator by selectively influencing T-cell differentiation; specifically, it promotes the production of interleukin-10 (IL-10) over interleukin-12 (IL-12) and induces regulatory T-cell subsets. This mechanism helps to restore the Th1/Th2 immunological balance that is typically disrupted in allergic conditions. It has been evaluated in Phase 3 clinical trials as a 1% solution for subcutaneous injection and is also available in other forms such as a nasal spray.

Brand names
Gencydo
Other names
Citrus/Cydonia comp.Citrus limon/Cydonia oblonga comp.Gencydo 1%
02

Targets

IL10 (Interleukin-10)IL12 (Interleukin-12)

Beyond the preview

Go deeper on Citrus + Cydonia comp..

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Citrus + Cydonia comp..

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call